Lennham Pharmaceuticals Announces Topline Results from Pharmacokinetic Study of D9-Caffeine Versus Caffeine

Written By Corey MacGregor

Read more

Corey MacGregor
Previous

Lennham Presents Topline Data From Human PK Study of D9-Caffeine vs Caffeine at ISSN 2021
Next

Lennham Pharmaceuticals Announces Issuance of U.S. Patent Covering Deuterated Psilocybin Products